These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5767511)

  • 1. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S; Wolański A
    Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modern aspects of pathogenesis in diabetes mellitus].
    Spanár E; Zahradny V; Uhrín P; Levcik A
    Z Gesamte Inn Med; 1974 Jun; 29(11):433-8. PubMed ID: 4849195
    [No Abstract]   [Full Text] [Related]  

  • 4. On the action of tolbutamide in normal man. I. Role of adrenergic mechanisms in tolbutamide-induced insulin release during normoglycaemia and induced hypoglycaemia.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):506-18. PubMed ID: 4739358
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
    Kadota I
    Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in the therapy of diabetes].
    Raptis S; Rothenbuchner G; Pfeiffer EF
    Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of propranolol on the action of tolbutamide].
    Specchia G; Fratino P; Gamba G
    Boll Soc Ital Biol Sper; 1970 Jun; 46(12):586-9. PubMed ID: 5496525
    [No Abstract]   [Full Text] [Related]  

  • 8. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
    Groop L; Tötterman KJ
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):410-5. PubMed ID: 7051722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dynamics of insulinemia in man after administration of tolbutamide].
    Lenti G; Pellegrini A; Pagano G; Mascia V; Cirillo R
    Minerva Med; 1968 Feb; 59(10):479-87. PubMed ID: 5642230
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
    Tötterman KJ; Groop LC
    Ann Clin Res; 1982 Aug; 14(4):190-3. PubMed ID: 6762846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic glucose counterregulation in patients with insulin-dependent diabetes mellitus.
    Cryer PE
    J Lab Clin Med; 1982 Apr; 99(4):451-6. PubMed ID: 6120983
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes mellitus: the thin maturity-onset diabetic.
    Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of tolbutamide on serum glucose level, specific activity of glucose and glucose oxidation in severe diabetes.
    Adlung J; Koch CD
    Int J Clin Pharmacol; 1974 Sep; 10(2):128-35. PubMed ID: 4448554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immediate effect of short-lasting insulin administration on the action of tolbutamide in diabetic patients].
    Grabowska MJ
    Pol Tyg Lek; 1967 Jul; 22(28):1064-6. PubMed ID: 6061141
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin-sensitivity and insulin-insensitivity in Indian diabetics as determined by the insulin tolerance test and their influence on the therapeutic response to tolbutamide].
    Singh I; Srivastava MC
    Acta Diabetol Lat; 1970; 7(5):767-76. PubMed ID: 5526500
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].
    Schulz E; Brinkmann W
    Dtsch Med Wochenschr; 1968 Mar; 93(11):485-91. PubMed ID: 5638113
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
    Cheah JS
    Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992
    [No Abstract]   [Full Text] [Related]  

  • 20. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.